Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight
Authors
Keywords
Cancer, HCC, Chemoresistance, Metastasis, Apoptosis, Autophagy
Journal
Cancer Cell International
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-04
DOI
10.1186/s12935-018-0538-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TGF-β2-induced EMT is dampened by inhibition of autophagy and TNF-α treatment
- (2018) Subhra Dash et al. Oncotarget
- FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
- (2017) Lixia Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
- (2017) Kai-chao Feng et al. Journal of Hematology & Oncology
- Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials
- (2017) Masatoshi Kudo ONCOLOGY
- A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers
- (2017) Bernard Escudier et al. Targeted Oncology
- Chimeric antigen receptor–engineered T cells for liver cancers, progress and obstacles
- (2017) Keyu Li et al. TUMOR BIOLOGY
- Phase III trial of linifanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC).
- (2017) Calin Cainap et al. JOURNAL OF CLINICAL ONCOLOGY
- Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery
- (2016) S C Katz et al. CANCER GENE THERAPY
- MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways
- (2016) Yanmin Xu et al. CANCER LETTERS
- Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
- (2016) Ghassan K. Abou-Alfa et al. JOURNAL OF HEPATOLOGY
- Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma
- (2016) Xiubing Zhang et al. PATHOLOGY RESEARCH AND PRACTICE
- p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming
- (2016) Tetsuya Saito et al. Nature Communications
- MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-κB signaling pathway
- (2016) Guosheng Tan et al. Scientific Reports
- Lenalidomide for Second-line Treatment of Advanced Hepatocellular Cancer
- (2015) Howard Safran et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Hepatic stellate cells: central modulators of hepatic carcinogenesis
- (2015) Alexandra I Thompson et al. BMC GASTROENTEROLOGY
- A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma
- (2015) Mairéad G. McNamara et al. CANCER
- Reciprocal interactions between mitral valve endothelial and interstitial cells reduce endothelial-to-mesenchymal transition and myofibroblastic activation
- (2015) Kayle Shapero et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Advances in targeted therapies for hepatocellular carcinoma in the genomic era
- (2015) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN
- (2015) KAI LIU et al. ONCOLOGY REPORTS
- Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients
- (2015) Maria Serova et al. Oncotarget
- Inhibition of p53 increases chemosensitivity to 5-FU in nutrient-deprived hepatocarcinoma cells by suppressing autophagy
- (2014) Xian-ling Guo et al. CANCER LETTERS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- TOP2Agene copy number change in breast cancer
- (2014) M J Engstrøm et al. JOURNAL OF CLINICAL PATHOLOGY
- Multiple functions of hypoxia-regulated miR-210 in cancer
- (2014) Qin Qin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Topoisomerase II-alfa gene as a predictive marker of response to anthracyclines in breast cancer
- (2014) Daniela Almeida et al. PATHOLOGY RESEARCH AND PRACTICE
- PharmGKB summary
- (2014) Srijib Goswami et al. Pharmacogenetics and Genomics
- Chinese Herbal Medicine Suppresses Invasion-Promoting Capacity of Cancer-Associated Fibroblasts in Pancreatic Cancer
- (2014) Lianyu Chen et al. PLoS One
- The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment
- (2013) Peixin Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Anticancer activity of an antisense oligonucleotide targeting TRADD combined with proteasome inhibitors in chemoresistant hepatocellular carcinoma cells
- (2013) Ewa Witort et al. JOURNAL OF CHEMOTHERAPY
- Hepatic stellate cells in liver development, regeneration, and cancer
- (2013) Chunyue Yin et al. JOURNAL OF CLINICAL INVESTIGATION
- Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
- (2013) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma
- (2013) Samiksha Bansal et al. JOURNAL OF SURGICAL RESEARCH
- The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached?
- (2013) Ghassan K Abou-Alfa et al. LANCET ONCOLOGY
- Tirapazamine Sensitizes Hepatocellular Carcinoma Cells to Topoisomerase I Inhibitors via Cooperative Modulation of Hypoxia-Inducible Factor-1
- (2013) T.-Y. Cai et al. MOLECULAR CANCER THERAPEUTICS
- Silencing of APE1 Enhances Sensitivity of Human Hepatocellular Carcinoma Cells to Radiotherapy In Vitro and in a Xenograft Model
- (2013) Yanping Cun et al. PLoS One
- Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma
- (2013) Min-Ae Song et al. PLoS One
- Genome-Wide Analysis of miRNA Signature Differentially Expressed in Doxorubicin-Resistant and Parental Human Hepatocellular Carcinoma Cell Lines
- (2013) Jufeng Zhang et al. PLoS One
- Cancer-Associated Fibroblasts from Hepatocellular Carcinoma Promote Malignant Cell Proliferation by HGF Secretion
- (2013) Chang-Chang Jia et al. PLoS One
- Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway
- (2013) Da-Liang Ou et al. PLoS One
- Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
- (2013) Baoxu Pang et al. Nature Communications
- Resistance to paclitaxel in hepatoma cells is related to static JNK activation and prohibition into entry of mitosis
- (2012) Sunyoung Chae et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells
- (2012) Zu-Yau Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Blockade of ataxia telangiectasia mutated sensitizes hepatoma cell lines to sorafenib by interfering with Akt signaling
- (2012) Shun Fujimaki et al. CANCER LETTERS
- Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein
- (2012) Leo L. Studach et al. HEPATOLOGY
- Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis
- (2012) Sandy Leung-Kuen Au et al. HEPATOLOGY
- High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma
- (2012) Chuanchao He et al. HUMAN PATHOLOGY
- Role of Mitochondrial Translocation of Telomerase in Hepatocellular Carcinoma Cells with Multidrug Resistance
- (2012) Xianlong Ling et al. International Journal of Medical Sciences
- Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma
- (2012) Yuanyuan Ruan et al. JOURNAL OF CLINICAL INVESTIGATION
- Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group
- (2012) Winnie Yeo et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma
- (2012) Xian-ling Guo et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts
- (2012) Zu-Yau Lin et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
- (2012) Armando Santoro et al. LANCET ONCOLOGY
- Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
- (2012) Cécile Guichard et al. NATURE GENETICS
- Emerging Signaling Pathways in Hepatocellular Carcinoma
- (2012) Agrin Moeini et al. Liver Cancer
- Overexpression of Long Non-coding RNA HOTAIR Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation
- (2011) Zhe Yang et al. ANNALS OF SURGICAL ONCOLOGY
- Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis
- (2011) Ying-Hong Shi et al. Autophagy
- FoxM1: A Master Regulator of Tumor Metastasis
- (2011) P. Raychaudhuri et al. CANCER RESEARCH
- Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation
- (2011) Z.-B. Ding et al. CLINICAL CANCER RESEARCH
- Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation
- (2011) Raquel Urtasun et al. HEPATOLOGY
- DNA Methylation-regulated miR-193a-3p Dictates Resistance of Hepatocellular Carcinoma to 5-Fluorouracil via Repression of SRSF2 Expression
- (2011) Kelong Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional analysis of microRNAs in human hepatocellular cancer stem cells
- (2011) Fanyin Meng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Phase II Study of the Mitogen-Activated Protein Kinase 1/2 Inhibitor Selumetinib in Patients With Advanced Hepatocellular Carcinoma
- (2011) Bert H. O'Neil et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened
- (2011) Xiao-Hui Huang et al. JOURNAL OF PATHOLOGY
- Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation
- (2011) Ming-chun Lai et al. MEDICAL ONCOLOGY
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
- (2011) Tom Luedde et al. Nature Reviews Gastroenterology & Hepatology
- MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells
- (2010) Y Tomimaru et al. BRITISH JOURNAL OF CANCER
- Combination of Human Fas (CD95/Apo-1) Ligand with Adriamycin Significantly Enhances the Efficacy of Antitumor Response
- (2010) Zhongchen Liu et al. Cellular & Molecular Immunology
- Hallmarks of cancer: Interactions with the tumor stroma
- (2010) Kristian Pietras et al. EXPERIMENTAL CELL RESEARCH
- Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells
- (2010) Eunyoung Tak et al. JOURNAL OF HEPATOLOGY
- Hepatocellular Carcinoma Displays Distinct DNA Methylation Signatures with Potential as Clinical Predictors
- (2010) Hector Hernandez-Vargas et al. PLoS One
- The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets
- (2010) Ju Dong Yang et al. SEMINARS IN CANCER BIOLOGY
- BRE over-expression promotes growth of hepatocellular carcinoma
- (2009) Yiu-Loon Chui et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
- (2009) Dawang Zhou et al. CANCER CELL
- Paclitaxel-resistance Conferred by Altered Expression of Efflux and Influx Transporters for Paclitaxel in the Human Hepatoma Cell Line, HepG2
- (2009) Mikihisa Takano et al. Drug Metabolism and Pharmacokinetics
- Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab
- (2009) Richard S Finn et al. Expert Review of Anticancer Therapy
- Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9
- (2009) Jing-song Chen et al. HEPATOLOGY RESEARCH
- The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines
- (2009) Brigette B.Y. Ma et al. INVESTIGATIONAL NEW DRUGS
- Testing Molecular Therapies in Hepatocellular Carcinoma: The Need for Randomized Phase II Trials
- (2009) Josep M. Llovet et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
- (2009) Andrew X. Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression and biological significance of c-FLIP in human hepatocellular carcinomas
- (2009) Xilin Du et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Selective ablation of Notch3 in HCC enhances doxorubicin’s death promoting effect by a p53 dependent mechanism
- (2009) Catia Giovannini et al. JOURNAL OF HEPATOLOGY
- Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
- (2009) Chun-Jen Liu et al. JOURNAL OF HEPATOLOGY
- Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cells
- (2009) Pau Sancho-Bru et al. LIVER INTERNATIONAL
- Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer
- (2009) Tao Gu et al. LUNG CANCER
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
- (2009) M. Olivier et al. Cold Spring Harbor Perspectives in Biology
- TIP30 Induces Apoptosis under Oxidative Stress through Stabilization of p53 Messenger RNA in Human Hepatocellular Carcinoma
- (2008) J. Zhao et al. CANCER RESEARCH
- Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma
- (2008) J. Montero et al. CANCER RESEARCH
- Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
- (2008) Ahmad Safa et al. CURRENT CANCER DRUG TARGETS
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
- Upregulation of miR-23a∼27a∼24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells
- (2008) Shenglin Huang et al. INTERNATIONAL JOURNAL OF CANCER
- TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance
- (2008) Nathalie Wong et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search